Dechra extends its otitis range with the addition of Osurnia - Veterinary Practice
Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×

Dechra extends its otitis range with the addition of Osurnia

Osurnia is a treatment for inflamed or infected canine ears that contains three active ingredients

Dechra Veterinary Products is pleased to announce the expansion of its range of products to treat otitis externa with the addition of Osurnia following the acquisition of the worldwide rights to the marketing and manufacture of the product from Elanco Animal Health Inc.

Osurnia, a treatment for inflamed or infected canine ears, contains three active ingredients: antibiotic florfenicol, terbinafine, which inhibits the growth of yeast as demonstrated for Malassezia spp., and the glucocorticosteroid, betamethasone acetate, to help relieve discomfort.

It is the same dose for any dog, regardless of size and weight and is easy to administer from a pre-measured, single-dose tube helping to ensure the right dose every time. It also has a flexible, soft tip that is gentle on a dog’s ears.

Osurnia is the latest addition to Dechra’s dermatology range that includes Canaural and Recicort and a range of ear cleaners.

Dechra Country Manager for the UK and ROI, Roddy Webster, said: “We know that otitis externa is a common challenge for both vets and clients with ear infections among the most frequent reasons for dogs to be presented at the vet clinic so we are delighted with the addition of Osurnia, which extends our range of solutions for veterinarians to manage otitis.

“We are now able to offer the best treatment for the pet taking into consideration the veterinarian’s clinical preference and the owner’s lifestyle. Dechra’s experience in otitis will bring a lot of added value to otitis externa management for veterinarians.”

Osurnia is available from veterinary wholesalers. For more information on Dechra’s otitis range, visit the website.

References

Nuttall, T. and Forster, S.

2015

Terbinafine and florfenicol concentrations in the canine ear canal exceed minimum inhibitory concentrations for common otic pathogens after treatment with Osurnia®(Elanco Animal Health). In Proceedings of the British Veterinary Dermatology Study Group spring meeting, Birmingham, UK (pp. 91-4)

Veterinary Practice

Improve Veterinary Practice (part of the Improve International Group) is an online knowledge and information hub for veterinary professionals across all specialties. It provides reliable, useful and interesting content, written by expert authors and covering small animal, large animal, exotics, equine and practice management
sectors of the veterinary surgeon and nursing professions.

Improve Veterinary Practice also offers a subscription-based membership, offering CPD courses and much more for the whole veterinary community.

Improve Veterinary Practice exists to inspire and inform your day-to-day work, and enable your ongoing professional development.


More from this author

Have you heard about our
IVP Membership?

A wide range of veterinary CPD and resources by leading veterinary professionals.

Stress-free CPD tracking and certification, you’ll wonder how you coped without it.

Discover more